Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Is EBRT after Y-90 safe for HCC patients?

05 Jun 2026

External beam radiation therapy (EBRT) after Yttrium-90 radioembolization (Y-90) does not appear to worsen hepatoxicity or inferior oncologic outcomes in patients with hepatocellular carcinoma (HCC) when compared with EBRT alone, a study has shown.

Is EBRT after Y-90 safe for HCC patients?

05 Jun 2026

Cabozantinib plus nivolumab, ipilimumab improves PFS in advanced renal cell carcinoma

05 Jun 2026 bởi

Adding cabozantinib to nivolumab and ipilimumab as first-line therapy, compared with placebo, results in prolonged progression-free survival (PFS) among untreated patients with advanced renal cell carcinoma (RCC), with no new safety signals seen, as shown by the results of the phase III COSMIC-313 study.

Cabozantinib plus nivolumab, ipilimumab improves PFS in advanced renal cell carcinoma

05 Jun 2026

FOLFIRI-ramucirumab shows promise as second-line therapy in advanced UGI cancers

05 Jun 2026

Combination therapy with FOLFIRI-ramucirumab exhibits survival advantage similar to ramucirumab plus paclitaxel in patients with advanced upper gastrointestinal (UGI) cancers, reveals a study. However, FOLFIRI-ramucirumab is associated with a longer real-world time to treatment discontinuation (rwTTD).

FOLFIRI-ramucirumab shows promise as second-line therapy in advanced UGI cancers

05 Jun 2026

Physical activity intensity matters more for chronic disease prevention

05 Jun 2026 bởi

Prioritizing physical activity (PA) intensity over volume may yield greater benefits for preventing most noncommunicable diseases (NCDs), a prospective study suggests.

Physical activity intensity matters more for chronic disease prevention

05 Jun 2026

Bempedoic acid beneficial in Asians with inadequately controlled hypercholesterolemia

05 Jun 2026

Treatment with bempedoic acid helps lower low‐density lipoprotein cholesterol (LDL‐C) levels in Asian patients who have LDL-C elevations despite receiving lipid-lowering therapy, including statins, according to a study from Taiwan.

Bempedoic acid beneficial in Asians with inadequately controlled hypercholesterolemia

05 Jun 2026

Sustained adherence to growth hormone therapy boosts growth outcomes in children

04 Jun 2026

Children maintaining a sustained adherence rate of at least 85 percent to daily growth hormone therapy see a clinically meaningful improvement in growth over 2 years, as shown in a retrospective study.

Sustained adherence to growth hormone therapy boosts growth outcomes in children

04 Jun 2026

One in eight young men in SG has dyslipidaemia

04 Jun 2026 bởi

Dyslipidaemia appears to be prevalent among adolescents and young men in Singapore, including those without traditional metabolic risk factors, according to local research.

One in eight young men in SG has dyslipidaemia

04 Jun 2026

Immunotherapy modestly improves response rates in HR+ breast cancer

04 Jun 2026

Patients with HR+/HER2‒ breast cancer treated with immunotherapy show modest improvements in complete response rates, reports a study.

Immunotherapy modestly improves response rates in HR+ breast cancer

04 Jun 2026

$Do calcium, vitamin D supplements prevent fractures, falls?$

Do calcium, vitamin D supplements prevent fractures, falls?

04 Jun 2026 bởi

The use of calcium, vitamin D, or combined supplementation does not appear helpful in preventing fractures and falls, claims a study.

Do calcium, vitamin D supplements prevent fractures, falls?

04 Jun 2026

Clipping before ECI lowers risk of ectopic embolisms in gastric varices

04 Jun 2026

Adding clip prior to endoscopic cyanoacrylate injection (ECI) helps prevent ectopic embolism in patients with fundal varices with a portal-systemic shunt, without compromising safety or efficacy, as shown in a recent study.

Clipping before ECI lowers risk of ectopic embolisms in gastric varices

04 Jun 2026

Tin tức & Cập nhật

Xem bài viết Đa khoa

Xem

Chuyên ngành:

Is EBRT after Y-90 safe for HCC patients?

Is EBRT after Y-90 safe for HCC patients?

Cabozantinib plus nivolumab, ipilimumab improves PFS in advanced renal cell carcinoma

Cabozantinib plus nivolumab, ipilimumab improves PFS in advanced renal cell carcinoma

FOLFIRI-ramucirumab shows promise as second-line therapy in advanced UGI cancers

FOLFIRI-ramucirumab shows promise as second-line therapy in advanced UGI cancers

Physical activity intensity matters more for chronic disease prevention

Physical activity intensity matters more for chronic disease prevention

Bempedoic acid beneficial in Asians with inadequately controlled hypercholesterolemia

Bempedoic acid beneficial in Asians with inadequately controlled hypercholesterolemia

Sustained adherence to growth hormone therapy boosts growth outcomes in children

Sustained adherence to growth hormone therapy boosts growth outcomes in children

One in eight young men in SG has dyslipidaemia

One in eight young men in SG has dyslipidaemia

Immunotherapy modestly improves response rates in HR+ breast cancer

Immunotherapy modestly improves response rates in HR+ breast cancer

Do calcium, vitamin D supplements prevent fractures, falls?

Do calcium, vitamin D supplements prevent fractures, falls?

Clipping before ECI lowers risk of ectopic embolisms in gastric varices

Clipping before ECI lowers risk of ectopic embolisms in gastric varices